| 2025-08-20 |
13D/A |
PRQR / ProQR Therapeutics N.V. |
Van Herk Investments B.v. |
12,202,190 |
11.60 |
6.09 |
| 2025-08-19 |
13D/A |
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) |
New Enterprise Associates 14, L.P. |
4 |
0.00 |
-100.00 |
| 2025-08-19 |
13D/A |
IOBT / IO Biotech, Inc. |
Novo Holdings A/S |
4,981,588 |
7.30 |
-14.46 |
| 2025-08-18 |
13D/A |
OSTX / OS Therapies Incorporated |
Auerbach Shalom |
2,677,570 |
8.50 |
-0.37 |
| 2025-08-18 |
13D/A |
CMPX / Compass Therapeutics, Inc. |
Commander Aggregator, LP |
7,788,150 |
4.50 |
|
| 2025-08-18 |
13D/A |
MRKR / Marker Therapeutics, Inc. |
New Enterprise Associates 16, L.P. |
1,625,678 |
12.60 |
0.00 |
| 2025-08-15 |
13D/A |
BHC / Bausch Health Companies Inc. |
Icahn Partners Master Fund LP |
0 |
0.00 |
-100.00 |
| 2025-08-15 |
13D/A |
CMPX / Compass Therapeutics, Inc. |
Orbimed Advisors Llc |
15,219,994 |
8.90 |
0.00 |
| 2025-08-15 |
13D/A |
ARWR / Arrowhead Pharmaceuticals, Inc. |
Sarepta Therapeutics, Inc. |
0 |
0.00 |
-100.00 |
| 2025-08-15 |
13D/A |
IRON / Disc Medicine, Inc. |
Atlas Venture Fund X, L.P. |
1,084,527 |
3.10 |
-22.65 |
| 2025-08-14 |
13D/A |
BHC / Bausch Health Companies Inc. |
Paulson & Co. Inc. |
70,755,869 |
19.10 |
115.77 |
| 2025-08-14 |
13D/A |
ACLX / Arcellx, Inc. |
New Enterprise Associates 15, L.P. |
3,055,360 |
5.51 |
-18.42 |
| 2025-08-14 |
13D/A |
BBIO / BridgeBio Pharma, Inc. |
Viking Global Investors Lp |
18,602,920 |
9.70 |
0.00 |
| 2025-08-14 |
13D/A |
SLDB / Solid Biosciences Inc. |
Ra Capital Management, L.p. |
7,997,510 |
9.90 |
|
| 2025-08-14 |
13D/A |
ORIC / ORIC Pharmaceuticals, Inc. |
Sr One Capital Management, Llc |
4,615,384 |
4.75 |
0.00 |
| 2025-08-13 |
13D/A |
AUPH / Aurinia Pharmaceuticals Inc. |
ILJIN SNT Co., Ltd. |
6,535,141 |
5.00 |
-13.33 |
| 2025-08-13 |
13D/A |
AVBP / ArriVent BioPharma, Inc. |
Orbimed Advisors Llc |
3,027,328 |
7.50 |
0.00 |
| 2025-08-13 |
13D |
CVAC / CureVac N.V. |
Glaxosmithkline Plc |
16,591,937 |
74.00 |
0.00 |
| 2025-08-13 |
13D |
PCSA / Processa Pharmaceuticals, Inc. |
HX Entertainment Ltd |
5,467,181 |
10.90 |
|
| 2025-08-12 |
13D/A |
ARMP / Armata Pharmaceuticals, Inc. |
Innoviva, Inc. |
55,467,459 |
83.30 |
-13.57 |
| 2025-08-12 |
13D/A |
HRTX / Heron Therapeutics, Inc. |
Rubric Capital Management LP |
29,100,728 |
17.50 |
8.94 |
| 2025-08-12 |
13D/A |
NAMS / NewAmsterdam Pharma Company N.V. |
Forbion Capital Fund IV Cooperatief U.A. |
10,578,806 |
9.40 |
-4.90 |
| 2025-08-11 |
13D/A |
TRVI / Trevi Therapeutics, Inc. |
New Enterprise Associates 16, L.P. |
15,074,080 |
12.00 |
0.00 |
| 2025-08-11 |
13D/A |
CDTX / Cidara Therapeutics, Inc. |
Ra Capital Management, L.p. |
3,365,523 |
13.30 |
0.00 |
| 2025-08-08 |
13D/A |
AMRX / Amneal Pharmaceuticals, Inc. |
Patel Chirag K. |
22,180,421 |
7.10 |
1.58 |
| 2025-08-08 |
13D |
PCRX / Pacira BioSciences, Inc. |
Doma Perpetual Capital Management LLC |
2,698,618 |
5.70 |
|
| 2025-08-07 |
13D/A |
EPIX / ESSA Pharma Inc. |
Biotechnology Value Fund L P |
11,668,473 |
24.70 |
33.37 |
| 2025-08-07 |
13D/A |
IMAB / I-Mab - Depositary Receipt (Common Stock) |
CBC Investment I-Mab Ltd |
27,492,595 |
10.40 |
-18.11 |
| 2025-08-06 |
13D/A |
STTK / Shattuck Labs, Inc. |
Redmile Group, LLC |
5,652,660 |
11.80 |
0.49 |
| 2025-08-05 |
13D |
IMAB / I-Mab - Depositary Receipt (Common Stock) |
Everest Medicines Limited |
42,524,716 |
16.10 |
|
| 2025-08-01 |
13D/A |
ALZN / Alzamend Neuro, Inc. |
Ault Milton C Iii |
706,322 |
18.50 |
-77.63 |
| 2025-08-01 |
13D/A |
CVAC / CureVac N.V. |
KfW |
112,841,355 |
50.10 |
-1.18 |
| 2025-08-01 |
13D/A |
SPRY / ARS Pharmaceuticals, Inc. |
Deerfield Mgmt III, L.P. |
7,610,217 |
7.75 |
-11.85 |
| 2025-07-31 |
13D/A |
LRMR / Larimar Therapeutics, Inc. |
Deerfield Private Design Fund III, L.P. |
30,667,474 |
35.81 |
|
| 2025-07-31 |
13D/A |
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock) |
Sofinnova Crossover I |
9,599,478 |
11.40 |
23.16 |
| 2025-07-29 |
13D/A |
IMA / ImageneBio, Inc. |
Atlas Venture Fund X, L.P. |
241,800 |
2.10 |
|
| 2025-07-29 |
13D/A |
INDV / Indivior PLC |
Two Seas Capital LP |
11,662,308 |
9.30 |
-3.50 |
| 2025-07-28 |
13D/A |
CELU / Celularity Inc. |
Dragasac Ltd |
14,138,161 |
41.00 |
42.26 |
| 2025-07-28 |
13D/A |
GLPG / Galapagos NV - Depositary Receipt (Common Stock) |
EcoR1 Capital, LLC |
8,714,522 |
13.22 |
11.68 |
| 2025-07-28 |
13D/A |
IMA / ImageneBio, Inc. |
BML Investment Partners, L.P. |
220,832 |
1.90 |
|
| 2025-07-25 |
13D/A |
BFRI / Biofrontera Inc. |
Deutsche Balaton Aktiengesellschaft |
458,884 |
4.86 |
0.00 |
| 2025-07-24 |
13D/A |
PASG / Passage Bio, Inc. |
Orbimed Advisors Llc |
132,473 |
4.25 |
-45.68 |
| 2025-07-22 |
13D/A |
SPRY / ARS Pharmaceuticals, Inc. |
Deerfield Mgmt III, L.P. |
8,633,537 |
8.79 |
-11.22 |
| 2025-07-22 |
13D/A |
BMEA / Biomea Fusion, Inc. |
Cormorant Global Healthcare Master Fund, LP |
3,681,664 |
6.46 |
2.53 |
| 2025-07-21 |
13D/A |
PASG / Passage Bio, Inc. |
Orbimed Advisors Llc |
243,878 |
7.82 |
-95.88 |
| 2025-07-21 |
13D/A |
EPIX / ESSA Pharma Inc. |
Soleus Capital Master Fund, L.P. |
4,362,026 |
9.80 |
92.84 |
| 2025-07-21 |
13D/A |
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock) |
Panacea Innovation Ltd |
13,950,000 |
25.10 |
4.03 |
| 2025-07-16 |
13D/A |
ONCO / Onconetix, Inc. |
Altos Venture AG |
273,230 |
35.80 |
|
| 2025-07-16 |
13D |
HYPD / Hyperion DeFi, Inc. |
Hyunsu Jung |
500,000 |
9.30 |
|
| 2025-07-15 |
13D/A |
RCUS / Arcus Biosciences, Inc. |
Gilead Sciences Inc |
31,424,760 |
29.70 |
-20.83 |
